Salem Radio Network News Sunday, September 26, 2021


EU regulator endorses AstraZeneca drug for rare blood disorder in children

(Reuters) – AstraZeneca said on Monday the European Medicines Agency (EMA) had recommended approving a medicine from its Alexion unit for treating a rare, deadly blood disorder in children and adolescents aged up to 18 years.

The drugmaker, which recently completed its $39 billion buyout of U.S.-based Alexion, said the drug Ultomiris had been given a positive opinion for paroxysmal nocturnal haemoglobinuria by the human medicines committee of the EMA.

(Reporting by Pushkala Aripaka in Bengaluru; Editing by Ramakrishnan M.)


Editorial Cartoons

View More »

Gary Varvel
Thu, Sep 16, 2021